← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications and studies (1942)
- Ugonin L ameliorates pulmonary fibrosis as a novel TβRs inhibitor by regulating the TGF-β/TβRs signaling and autophagy. (2025/08/01) ♡
- Homology-feature-assisted quantification of fibrotic lesions in computed tomography images: a proof of concept for CT image feature-based prediction for gene-expression-distribution. (2025/08/01) ♡
- Comprehensive analysis of molecular characteristic and clinical prognosis of CD8+ T cell related genes in idiopathic pulmonary fibrosis. (2025/07/31) ♡
- Qingfeiyin decoction in idiopathic pulmonary fibrosis: Lung-targeted components and PI3K-AKT modulation. (2025/07/24) ♡
- Shared pathogenic mechanisms linking obesity and idiopathic pulmonary fibrosis revealed by bioinformatics and in vivo validation. (2025/07/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New therapeutic approaches for fibrosis: harnessing translational regulation. (2025/07/01) ♡
- Mechanism study of the effects of astragaloside IV and quercetin on idiopathic pulmonary fibrosis. (2025/07/01) ♡
- [Buyang Huanwu Decoction targets PPARG/SPP1/CD44 signaling pathway: mechanisms of lipid dysregulation and treatment in idiopathic pulmonary fibrosis]. (2025/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fibrosis: cross-organ biology and pathways to development of innovative drugs. (2025/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Idiopathic pleuroparenchymal fibroelastosis: diagnosis and management. (2025/07/01) ♡
- The Relationship Between Chest Wall Muscle Thickness, Pulmonary Function, and Prognostic Markers in Idiopathic Pulmonary Fibrosis. (2025/06/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Double-Lung Transplant With Delayed Nuss Bar Prostheses for Pectus Excavatum Deformity. (2025/06/25) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Dahuang Zhechong pill alleviates pulmonary fibrosis by inhibiting apoptosis and epithelial-mesenchymal transition of type II alveolar epithelial cells in vitro and in vivo. (2025/06/14) ♡
- Baihe Gujin decoction attenuates idiopathic pulmonary fibrosis via regulating proline metabolism. (2025/06/12) ♡
- Efficacy of umbelliferone-loaded nanostructured lipid carrier in the management of bleomycin-induced idiopathic pulmonary fibrosis: experimental and network pharmacology insight. (2025/06/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Self-assembled vectors derived from Aster tataricus L.f. mitigate bleomycin-induced pulmonary fibrosis in mice. (2025/05/29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis. (2025/05/29) ♡
- Anti-fibrotic effects of Saengmaek-san, a prescription of traditional Korean medicine in bleomycin-induced pulmonary fibrosis mice model. (2025/05/28) ♡
- Associations between leisure sedentary behaviors, physical activity, and chronic respiratory diseases: a Mendelian randomization study. (2025/05/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Insights into interstitial lung disease pathogenesis. (2025/05/13) ♡
- Effective-compounds of Jinshui Huanxian Formula acts as an SRC inhibitor to inhibit HK2-mediated H3K18 lactation and improve pulmonary fibrosis. (2025/05/01) ♡
- [Exploration of pharmacodynamic material basis and mechanism of Jinbei Oral Liquid against idiopathic pulmonary fibrosis based on UHPLC-Q-TOF-MS/MS and network pharmacology]. (2025/05/01) ♡
- Dynapenia and Sarcopenia as Risk Factors for Mortality in Interstitial Lung Disease. (2025/05/01) ♡
- Inhalable Hsa-miR-30a-3p Liposomes Attenuate Pulmonary Fibrosis. (2025/05/01) ♡
- Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases. (2025/04/28) ♡
- Studying the efficacy of JBOL volatile components in idiopathic pulmonary fibrosis (IPF) using GC-MS and network pharmacology. (2025/04/16) ♡
- Gui-zhi-fu-ling-wan alleviates bleomycin-induced pulmonary fibrosis through inhibiting epithelial-mesenchymal transition and ferroptosis. (2025/04/16) ♡
- Maimendong decoction modulates the PINK1/Parkin signaling pathway alleviates type 2 alveolar epithelial cells senescence and enhances mitochondrial autophagy to offer potential therapeutic effects for idiopathic pulmonary fibrosis. (2025/04/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What rationale for treatment of occupational interstitial lung diseases with the drugs approved for idiopathic pulmonary fibrosis? (2025/04/01) ♡
- The Nutritional Phenotyping of Idiopathic Pulmonary Fibrosis Through Morphofunctional Assessment: A Bicentric Cross-Sectional Case-Control Study. (2025/03/21) ♡
- A Targeted Mass Spectrometric Approach to Evaluate the Anti-Inflammatory Activity of the Major Metabolites of Foeniculum vulgare Mill. Waste in Human Bronchial Epithelium. (2025/03/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of TRP channels in lung fibrosis: Mechanisms and therapeutic potential. (2025/03/01) ♡
- Systemic immune-inflammation index in the evaluation of Sjogren's syndrome associated with interstitial lung disease, interstitial pneumonia with autoimmune features, and idiopathic pulmonary fibrosis. (2025/03/01) ♡
- Diagnosis of Fibrotic Interstitial Lung Diseases Based on the Combination of Label-Free Quantitative Multiphoton Fiber Histology and Machine Learning. (2025/03/01) ♡
- Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft-Versus-Host Disease. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-Pharmacological Management of Idiopathic Pulmonary Fibrosis. (2025/02/17) ♡
- Discovery of novel capsaicin analogs as TRPV1 inhibitors for the treatment of idiopathic pulmonary fibrosis. (2025/02/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Beneficial Impact of Nutritional Therapy on Idiopathic Pulmonary Fibrosis. (2025/02/05) ♡
- JUNB O-GlcNAcylation-Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis. (2025/02/01) ♡
- The potential lipid biomarker 5-HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis. (2025/02/01) ♡
- Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE-BUILD) pilot study. (2025/02/01) ♡
- Diagnostic and predictive values of m5C‑associated genes in idiopathic pulmonary fibrosis. (2025/02/01) ♡
- Computed tomography morphomics and antifibrotic therapy in idiopathic pulmonary fibrosis. (2025/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan. (2025/02/01) ♡
- Nonmalignant respiratory disease mortality among dentists in the United States from 1979 through 2018. (2025/02/01) ♡
- Improving functional correlation of quantification of interstitial lung disease by reducing the vendor difference of CT using generative adversarial network (GAN) style conversion. (2025/02/01) ♡
- Serum cholesterol levels predict the survival in patients with idiopathic pulmonary fibrosis: A long-term follow up study. (2025/02/01) ♡
- Identifying health risk determinants and molecular targets in patients with idiopathic pulmonary fibrosis via combined differential and weighted gene co-expression analysis. (2025/01/29) ♡
- Pirfenidone microcrystals for pulmonary delivery: Regulation of the precipitation behavior in the supercooled droplet. (2025/01/25) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial. (2025/01/23) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.